Microbial interactions in otitis media

中耳炎中的微生物相互作用

基本信息

项目摘要

DESCRIPTION (provided by applicant): This project aims to define how polymicrobial infection impacts the development, severity, and treatment of bacterial otitis media. Haemophilus influenzae (Hi) is the leading bacterial species associated with otitis media, and our data show that coinfection with multiple strains of Hi is common. We hypothesize that strains of Hi undergo intrastrain and interstrain quorum signaling and horizontal gene transfer within biofilm communities which impacts strain diversity and horizontal dissemination of virulence determinants. In order to address these hypotheses we will complete the following Specific Aims: Specific Aim 1. To understand relationships between Hi strains with differing production and/or sensing of quorum signal Specific Aim 2. To ask how different inters train relationships affect bacterial persistence and disease severity in the chinchilla infection model Specific Aim 3. To define emergence and dissemination of virulence determinants among Hi strains within the same biofilm community. Otitis media is among the most common pediatric infectious diseases, affecting the majority of children and accounting for billions of dollars in ttal health-care costs per year. It is clear that a significant proportion of these infections are cause by Hi, for which there is no currently licensed vaccine. Unfortunately, our ability to treat these infections is increasingly limited by the continued emergence of antibiotic-resistant bacterial strains. The results of these studies will provide significant insight into how different Hi strain act competitively and/or cooperatively during infection. Moreover, we will gain significant new information regarding how new genotypes emerge and are disseminated within a biofilm community. These findings will be crucial steps in gaining the deep understanding of basic mechanisms for persistence and virulence that will be necessary for tailoring new strategies for diagnosis, prevention, and/or therapy of otitis media infections.
描述(由申请人提供):本项目旨在确定多种微生物感染如何影响细菌性中耳炎的发展、严重程度和治疗。流感嗜血杆菌(Hi)是与中耳炎相关的主要细菌种类,我们的数据显示,同时感染多种Hi菌株是常见的。我们假设Hi菌株在生物膜群落中经历了种内和种间的群体信号和水平基因转移,从而影响了菌株多样性和毒力决定因素的水平传播。为了解决这些假设,我们将完成以下具体目标:了解具有不同产量和/或感应群体信号的Hi菌株之间的关系。在栗鼠感染模型中,不同的训练关系如何影响细菌持久性和疾病严重程度?定义同一生物膜群落内Hi毒株中毒力决定因素的出现和传播。中耳炎是最常见的儿科传染病之一,影响大多数儿童,每年的医疗保健费用总额达数十亿美元。很明显,这些感染中有很大一部分是由Hi引起的,目前还没有获得许可的疫苗。不幸的是,我们治疗这些感染的能力越来越受到抗生素耐药菌株不断出现的限制。这些研究的结果将为不同的Hi毒株在感染过程中如何竞争和/或合作提供重要的见解。此外,我们将获得关于新基因型如何在生物膜群落中出现和传播的重要新信息。这些发现将是深入了解持续性和毒性基本机制的关键步骤,这将是制定诊断、预防和/或治疗中耳炎感染的新策略所必需的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

David Arnold Ornelles其他文献

David Arnold Ornelles的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('David Arnold Ornelles', 18)}}的其他基金

Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    7584310
  • 财政年份:
    2009
  • 资助金额:
    $ 36.4万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    8212400
  • 财政年份:
    2009
  • 资助金额:
    $ 36.4万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    8449686
  • 财政年份:
    2009
  • 资助金额:
    $ 36.4万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    7909155
  • 财政年份:
    2009
  • 资助金额:
    $ 36.4万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    8017437
  • 财政年份:
    2009
  • 资助金额:
    $ 36.4万
  • 项目类别:
Prenatal adenovirus infection, inhibition of DNA repair, and childhood leukemia
产前腺病毒感染、DNA 修复抑制和儿童白血病
  • 批准号:
    7807094
  • 财政年份:
    2009
  • 资助金额:
    $ 36.4万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6376678
  • 财政年份:
    1999
  • 资助金额:
    $ 36.4万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6740286
  • 财政年份:
    1999
  • 资助金额:
    $ 36.4万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6513387
  • 财政年份:
    1999
  • 资助金额:
    $ 36.4万
  • 项目类别:
NOVEL CELL CYCLE REGULATION BY ADENOVIRUS E1B 55K
腺病毒 E1B 55K 对细胞周期的新型调控
  • 批准号:
    6464597
  • 财政年份:
    1999
  • 资助金额:
    $ 36.4万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 36.4万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了